Kassa Getahun Molla, Lim Aaron G, Tamiru Melaku Tileku, Alamneh Tesfa Sewunet, Vickerman Peter, Dagne Emebet, Mulu Andargachew, Baissa Obsie, Paltiel Ora, Dillon John F, Yesuf Elias Ali, Hickman Matthew, Walker Josephine G, French Clare E
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
J Viral Hepat. 2025 Oct;32(10):e70065. doi: 10.1111/jvh.70065.
Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). Comprehensive systematic review of HCV seroprevalence of community-based observational studies reporting HCV risk factors in SSA. Study quality was assessed using Joanna Briggs Institute tool. Random effect meta-analyses were used to estimate odds ratios (OR) with 95% confidence intervals (CI). We identified 92 studies. Higher odds of HCV seroprevalence were observed among age 21-64 (OR = 1.77, 95% CI 1.17-2.68) and 65+ groups (OR = 11.75, 95% CI 5.51-25.05) compared to those aged ≤ 20 years; not being formally educated (OR = 1.78, 95% CI 1.35-2.35) compared to secondary/above and being married (OR = 1.91, 95% CI 1.45-2.51) or divorced (OR = 3.20, 95% CI 1.91-5.36) compared to never married. Family history of HCV (OR = 1.52, 95% CI 1.17-1.96), being a person living with HIV (OR = 2.64, 95% CI 1.61-4.33) or being HBsAg positive (OR = 1.66, 95% CI 1.10-2.50) were all positively associated with increased HCV seroprevalence, as was having a history of blood transfusion (OR = 1.81, 95% CI 1.33-2.45), hospitalisation (OR = 1.55, 95% CI 1.22-1.96), medical operation (OR = 1.28, 95% CI 1.01-1.62), scarification (OR = 1.29, 95% CI 1.01-1.64) and injection drug use (OR = 7.04, 95% CI 1.16-42.68). Pilot HCV screening programmes targeting older adults and people exposed to healthcare-associated factors could potentially lead to the efficient detection of HCV cases and reduce future HCV exposures among the general population in SSA countries.
了解丙型肝炎病毒(HCV)的风险因素对于确定筛查和预防目标至关重要。我们系统回顾了撒哈拉以南非洲(SSA)普通人群中与HCV血清流行率相关的风险因素。对SSA中报告HCV风险因素的基于社区的观察性研究的HCV血清流行率进行全面系统回顾。使用乔安娜·布里格斯研究所工具评估研究质量。采用随机效应荟萃分析来估计比值比(OR)及95%置信区间(CI)。我们纳入了92项研究。与年龄≤20岁的人群相比,21 - 64岁组(OR = 1.77,95% CI 1.17 - 2.68)和65岁及以上组(OR = 11.75,95% CI 5.51 - 25.05)的HCV血清流行率较高;与接受过中等及以上教育的人群相比,未接受过正规教育的人群(OR = 1.78,95% CI 1.35 - 2.35),与从未结婚的人群相比,已婚人群(OR = 1.91,95% CI 1.45 - 2.51)或离婚人群(OR = 3.20,95% CI 1.91 - 5.36)的HCV血清流行率较高。HCV家族史(OR = 1.52,95% CI 1.17 - 1.96)、感染艾滋病毒者(OR = 2.64,95% CI 1.61 - 4.33)或乙肝表面抗原阳性者(OR = 1.66,95% CI 1.10 - 2.50)均与HCV血清流行率增加呈正相关,有输血史(OR = 1.81,95% CI 1.33 - 2.45)、住院史(OR = 1.55,95% CI 1.22 - 1.96)、手术史(OR = 1.28,95% CI 1.01 - 1.62)、划痕纹身史(OR = 1.29,95% CI 1.01 - 1.64)和注射吸毒史(OR = 7.04,95% CI 1.16 - 42.68)也呈正相关。针对老年人和接触医疗相关因素人群的HCV筛查试点项目可能会有效检测出HCV病例,并减少SSA国家普通人群未来的HCV暴露。